(RMS) Hermes International SCA - Ratings and Ratios
Exchange: PA •
Country: France •
Currency: EUR •
Type: Common Stock •
ISIN: FR0000052292
Leather goods, Ready-to-wear, Accessories, Silk, Perfumes
Dividends
| Dividend Yield | 1.03% |
| Yield on Cost 5y | 3.11% |
| Yield CAGR 5y | 54.61% |
| Payout Consistency | 97.1% |
| Payout Ratio | 37.5% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 25.1% |
| Value at Risk 5%th | 39.0% |
| Relative Tail Risk | -5.57% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.89 |
| Alpha | -27.16 |
| CAGR/Max DD | 0.29 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.420 |
| Beta | 0.359 |
| Beta Downside | 0.309 |
| Drawdowns 3y | |
|---|---|
| Max DD | 28.14% |
| Mean DD | 10.65% |
| Median DD | 9.39% |
Description: RMS Hermes International SCA December 01, 2025
Hermès International SCA (ticker RMS) is a French luxury group that designs, manufactures, and sells a broad portfolio of high-end products-including leather goods, ready-to-wear, accessories, silk, perfume, watches, and tableware-through its own boutiques worldwide and a limited set of specialty distributors.
In FY 2023 the company generated €12.2 billion in revenue, with an operating margin of roughly 30 %, reflecting the premium pricing power typical of the ultra-luxury segment. Growth was led by Asia-Pacific (especially China and Japan), where sales rose ~12 % year-over-year, while the U.S. market delivered modest double-digit growth despite a softer macro environment.
Key economic drivers for Hermès include the resilience of discretionary spending among high-net-worth consumers, the relative weakness of the euro against the dollar (which boosts reported earnings), and the limited exposure to mass-market e-commerce that preserves brand exclusivity. Conversely, the firm remains vulnerable to geopolitical tensions that could disrupt its Asian supply chain or dampen affluent travel-related demand.
For a data-driven deep-dive into Hermès’ valuation metrics and scenario analysis, you may find ValueRay’s research platform a useful next step.
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income: 6.85b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.41 > 0.02 and ΔFCF/TA 23.53 > 1.0 |
| NWC/Revenue: 48.18% < 20% (prev 80.62%; Δ -32.44% < -1%) |
| CFO/TA 0.45 > 3% & CFO 9.83b > Net Income 6.85b |
| Net Debt (-8.26b) to EBITDA (10.82b): -0.76 < 3 |
| Current Ratio: 4.50 > 1.5 & < 3 |
| Outstanding Shares: last quarter (105.0m) vs 12m ago 0.02% < -2% |
| Gross Margin: 68.88% > 18% (prev 0.70%; Δ 6818 % > 0.5%) |
| Asset Turnover: 109.8% > 50% (prev 65.67%; Δ 44.11% > 0%) |
| Interest Coverage Ratio: 112.8 > 6 (EBITDA TTM 10.82b / Interest Expense TTM 85.0m) |
Altman Z'' 10.00
| A: 0.51 (Total Current Assets 14.37b - Total Current Liabilities 3.19b) / Total Assets 21.83b |
| B: 0.10 (Retained Earnings 2.25b / Total Assets 21.83b) |
| C: 0.45 (EBIT TTM 9.59b / Avg Total Assets 21.14b) |
| D: 3.31 (Book Value of Equity 17.23b / Total Liabilities 5.21b) |
| Altman-Z'' Score: 10.21 = AAA |
Beneish M -2.90
| DSRI: 0.61 (Receivables 506.0m/482.0m, Revenue 23.20b/13.43b) |
| GMI: 1.02 (GM 68.88% / 69.99%) |
| AQI: 1.10 (AQ_t 0.13 / AQ_t-1 0.12) |
| SGI: 1.73 (Revenue 23.20b / 13.43b) |
| TATA: -0.14 (NI 6.85b - CFO 9.83b) / TA 21.83b) |
| Beneish M-Score: -2.90 = A |
ValueRay F-Score (Strict, 0-100) 89.63
| 1. Piotroski: 7.50pt |
| 2. FCF Yield: 4.17% |
| 3. FCF Margin: 38.63% |
| 4. Debt/Equity: 0.12 |
| 5. Debt/Ebitda: -0.76 |
| 6. ROIC - WACC: 30.80% |
| 7. RoE: 42.68% |
| 8. Revenue Trend: 98.31% |
| 9. EPS Trend: 3.56% |
What is the price of RMS shares?
As of January 25, 2026, the stock is trading at EUR 2130.00 with a total of 56,270 shares traded.
Over the past week, the price has changed by -2.74%, over one month by +2.31%, over three months by -2.92% and over the past year by -18.44%.
Over the past week, the price has changed by -2.74%, over one month by +2.31%, over three months by -2.92% and over the past year by -18.44%.
Is RMS a buy, sell or hold?
Hermes International SCA has no consensus analysts rating.
What are the forecasts/targets for the RMS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 2367.5 | 11.2% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 2238.2 | 5.1% |
RMS Fundamental Data Overview January 20, 2026
Market Cap USD = 258.58b (221.52b EUR * 1.1673 EUR.USD)
P/E Trailing = 49.4732
P/E Forward = 45.6621
P/S = 14.1095
P/B = 13.8291
P/EG = 4.764
Revenue TTM = 23.20b EUR
EBIT TTM = 9.59b EUR
EBITDA TTM = 10.82b EUR
Long Term Debt = 30.0m EUR (from longTermDebt, last quarter)
Short Term Debt = 336.0m EUR (from shortTermDebt, last quarter)
Debt = 2.06b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = -8.26b EUR (from netDebt column, last quarter)
Enterprise Value = 215.19b EUR (221.52b + Debt 2.06b - CCE 8.39b)
Interest Coverage Ratio = 112.8 (Ebit TTM 9.59b / Interest Expense TTM 85.0m)
EV/FCF = 24.01x (Enterprise Value 215.19b / FCF TTM 8.96b)
FCF Yield = 4.17% (FCF TTM 8.96b / Enterprise Value 215.19b)
FCF Margin = 38.63% (FCF TTM 8.96b / Revenue TTM 23.20b)
Net Margin = 29.52% (Net Income TTM 6.85b / Revenue TTM 23.20b)
Gross Margin = 68.88% ((Revenue TTM 23.20b - Cost of Revenue TTM 7.22b) / Revenue TTM)
Gross Margin QoQ = 66.27% (prev none%)
Tobins Q-Ratio = 9.86 (Enterprise Value 215.19b / Total Assets 21.83b)
Interest Expense / Debt = 1.26% (Interest Expense 26.0m / Debt 2.06b)
Taxrate = 35.13% (1.23b / 3.50b)
NOPAT = 6.22b (EBIT 9.59b * (1 - 35.13%))
Current Ratio = 4.50 (Total Current Assets 14.37b / Total Current Liabilities 3.19b)
Debt / Equity = 0.12 (Debt 2.06b / totalStockholderEquity, last quarter 16.60b)
Debt / EBITDA = -0.76 (Net Debt -8.26b / EBITDA 10.82b)
Debt / FCF = -0.92 (Net Debt -8.26b / FCF TTM 8.96b)
Total Stockholder Equity = 16.05b (last 4 quarters mean from totalStockholderEquity)
RoA = 32.40% (Net Income 6.85b / Total Assets 21.83b)
RoE = 42.68% (Net Income TTM 6.85b / Total Stockholder Equity 16.05b)
RoCE = 59.64% (EBIT 9.59b / Capital Employed (Equity 16.05b + L.T.Debt 30.0m))
RoIC = 37.98% (NOPAT 6.22b / Invested Capital 16.37b)
WACC = 7.18% (E(221.52b)/V(223.58b) * Re(7.24%) + D(2.06b)/V(223.58b) * Rd(1.26%) * (1-Tc(0.35)))
Discount Rate = 7.24% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 33.33 | Cagr: 0.01%
[DCF Debug] Terminal Value 83.97% ; FCFF base≈6.81b ; Y1≈8.40b ; Y5≈14.31b
Fair Price DCF = 2842 (EV 289.66b - Net Debt -8.26b = Equity 297.92b / Shares 104.8m; r=7.18% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 3.56 | EPS CAGR: -52.63% | SUE: 0.0 | # QB: 0
Revenue Correlation: 98.31 | Revenue CAGR: 37.73% | SUE: 0.87 | # QB: 1
EPS next Year (2026-12-31): EPS=47.57 | Chg30d=-0.558 | Revisions Net=-5 | Growth EPS=+12.3% | Growth Revenue=+8.0%
P/E Trailing = 49.4732
P/E Forward = 45.6621
P/S = 14.1095
P/B = 13.8291
P/EG = 4.764
Revenue TTM = 23.20b EUR
EBIT TTM = 9.59b EUR
EBITDA TTM = 10.82b EUR
Long Term Debt = 30.0m EUR (from longTermDebt, last quarter)
Short Term Debt = 336.0m EUR (from shortTermDebt, last quarter)
Debt = 2.06b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = -8.26b EUR (from netDebt column, last quarter)
Enterprise Value = 215.19b EUR (221.52b + Debt 2.06b - CCE 8.39b)
Interest Coverage Ratio = 112.8 (Ebit TTM 9.59b / Interest Expense TTM 85.0m)
EV/FCF = 24.01x (Enterprise Value 215.19b / FCF TTM 8.96b)
FCF Yield = 4.17% (FCF TTM 8.96b / Enterprise Value 215.19b)
FCF Margin = 38.63% (FCF TTM 8.96b / Revenue TTM 23.20b)
Net Margin = 29.52% (Net Income TTM 6.85b / Revenue TTM 23.20b)
Gross Margin = 68.88% ((Revenue TTM 23.20b - Cost of Revenue TTM 7.22b) / Revenue TTM)
Gross Margin QoQ = 66.27% (prev none%)
Tobins Q-Ratio = 9.86 (Enterprise Value 215.19b / Total Assets 21.83b)
Interest Expense / Debt = 1.26% (Interest Expense 26.0m / Debt 2.06b)
Taxrate = 35.13% (1.23b / 3.50b)
NOPAT = 6.22b (EBIT 9.59b * (1 - 35.13%))
Current Ratio = 4.50 (Total Current Assets 14.37b / Total Current Liabilities 3.19b)
Debt / Equity = 0.12 (Debt 2.06b / totalStockholderEquity, last quarter 16.60b)
Debt / EBITDA = -0.76 (Net Debt -8.26b / EBITDA 10.82b)
Debt / FCF = -0.92 (Net Debt -8.26b / FCF TTM 8.96b)
Total Stockholder Equity = 16.05b (last 4 quarters mean from totalStockholderEquity)
RoA = 32.40% (Net Income 6.85b / Total Assets 21.83b)
RoE = 42.68% (Net Income TTM 6.85b / Total Stockholder Equity 16.05b)
RoCE = 59.64% (EBIT 9.59b / Capital Employed (Equity 16.05b + L.T.Debt 30.0m))
RoIC = 37.98% (NOPAT 6.22b / Invested Capital 16.37b)
WACC = 7.18% (E(221.52b)/V(223.58b) * Re(7.24%) + D(2.06b)/V(223.58b) * Rd(1.26%) * (1-Tc(0.35)))
Discount Rate = 7.24% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 33.33 | Cagr: 0.01%
[DCF Debug] Terminal Value 83.97% ; FCFF base≈6.81b ; Y1≈8.40b ; Y5≈14.31b
Fair Price DCF = 2842 (EV 289.66b - Net Debt -8.26b = Equity 297.92b / Shares 104.8m; r=7.18% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 3.56 | EPS CAGR: -52.63% | SUE: 0.0 | # QB: 0
Revenue Correlation: 98.31 | Revenue CAGR: 37.73% | SUE: 0.87 | # QB: 1
EPS next Year (2026-12-31): EPS=47.57 | Chg30d=-0.558 | Revisions Net=-5 | Growth EPS=+12.3% | Growth Revenue=+8.0%